SMOT - ETF AI Analysis
Top Page
VanEck Morningstar SMID Moat ETF (SMOT)
SMOT, the VanEck Morningstar SMID Moat ETF, earns a solid overall rating largely because several key holdings like Devon Energy, Veralto, Elevance Health, and GE Healthcare show strong financial performance, positive earnings commentary, and generally favorable momentum, which support the fund’s quality. However, weaker names such as Lamb Weston and Estée Lauder, which face margin pressure, leverage concerns, and profitability challenges, slightly weigh on the rating. A main risk factor is that some top holdings appear overvalued or have mixed short‑term technical trends, which could increase volatility for investors.
SMOT vs. SPDR S&P 500 ETF (SPY)
- AUM
- 322.75M
- Region
- North America
- Expense Ratio
- 0.49%
- Beta
- 0.82
- Issuer
- VanEck
- Inception Date
- Oct 04, 2022
- Dividend Yield
- 1.23%
- Asset Class
- Equity
- Index Tracked
- Morningstar US Small-Mid Cap Moat Focus
SMOT Summary
SMOT is the VanEck Morningstar SMID Moat ETF, which follows the Morningstar US Small-Mid Cap Moat Focus Index. It invests in U.S. small and mid-sized companies that Morningstar believes have strong, lasting business advantages. The fund spreads money across many sectors, including health care, industrials, and consumer goods, and holds well-known names like Becton Dickinson and Estée Lauder. Someone might invest in SMOT to seek long-term growth and diversify beyond the usual large-company funds. A key risk is that smaller and mid-sized stocks can be more volatile, so the ETF’s value can go up and down sharply with the market.
How much will it cost me?
This ETF has an expense ratio of 0.49%, which means you’ll pay about $4.90 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because this fund is more actively managed, using Morningstar’s moat-focused research to pick specific small- and mid-cap stocks.
What would affect this ETF?
SMOT could benefit if the U.S. economy grows steadily, supporting small and mid-sized companies in health care, industrials, and consumer sectors, and if its moat-focused holdings like Becton Dickinson and Elevance Health continue to strengthen their competitive positions. On the downside, higher interest rates, an economic slowdown that hits smaller companies harder, or sector-specific challenges in areas like consumer goods and energy could weigh on the ETF’s future performance.
SMOT Top 10 Holdings
SMOT leans heavily into U.S. health care and consumer names, and that’s where much of the story sits. Becton Dickinson and GE Healthcare are steady-to-rising anchors, helping drive returns from the fund’s sizable health care sleeve. On the consumer side, Lamb Weston has been a quiet overachiever, while Estée Lauder looks more like a comeback story in progress than a clear winner. Devon Energy adds a rising cyclical kick, but its smaller weight keeps it from steering the ship. Overall, performance is driven by a mix of resilient moaty growers with a few laggards still finding their footing.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 BDX | Becton Dickinson | 1.58% | $5.10M | $53.90B | 10.31% | 67Neutral |
 EL | The Estée Lauder Companies | 1.51% | $4.86M | $39.58B | 11.90% | 56Neutral |
 MAS | Masco | 1.50% | $4.83M | $15.54B | 24.08% | 53Neutral |
 LW | Lamb Weston Holdings | 1.49% | $4.81M | $7.45B | -13.04% | 61Neutral |
 VLTO | Veralto Corporation | 1.49% | $4.81M | $27.09B | 10.68% | 76Outperform |
 GEHC | GE Healthcare Technologies Inc | 1.48% | $4.78M | $34.62B | 2.09% | 78Outperform |
 AMCR | Amcor | 1.47% | $4.74M | $21.91B | 20.74% | 73Outperform |
 DVN | Devon Energy | 1.46% | $4.72M | $57.37B | 62.92% | 79Outperform |
 GPN | Global Payments | 1.45% | $4.69M | $25.63B | 23.07% | 70Outperform |
 HII | Huntington Ingalls | 1.42% | $4.57M | $12.49B | -0.69% | 69Neutral |
SMOT Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMOT, the sentiment is Positive. The current price of 40.61 is above the 20-day moving average (MA) of 39.07, above the 50-day MA of 39.22, and above the 200-day MA of 38.09, indicating a bullish trend. The MACD of 0.44 indicates Negative momentum. The RSI at 68.94 is Neutral, neither overbought nor oversold. The STOCH value of 85.57 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SMOT.
SMOT Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| SMOT | $40.61 | $43.00(5.89% Upside) | $322.75M | 0.49% | 68Neutral |
 RSMC | $27.31 | $34.56(26.54% Upside) | $737.68M | 0.75% | 69Neutral |
 MSSM | $57.94 | $73.09(26.15% Upside) | $708.38M | 0.62% | 64Neutral |
 GRNJ | $25.97 | $39.48(52.01% Upside) | $466.02M | 0.75% | 69Neutral |
 ASCE | $32.42 | $42.14(29.98% Upside) | $354.77M | 0.38% | 71Outperform |
 ISMD | $46.88 | $60.04(28.08% Upside) | $335.23M | 0.53% | 65Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SMOT | VanEck Morningstar SMID Moat ETF | 40.61 | 5.78 | 16.58% | |
| RSMC | Rockefeller U.S. Small-Mid Cap ETF | 27.31 | 1.96 | 7.73% | |
| MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | 57.94 | 8.92 | 18.21% | |
| GRNJ | Fundstrat Granny Shots US Small- & Mid-Cap ETF | 25.97 | 1.67 | 6.87% | |
| ASCE | Allspring SMID Core ETF | 32.42 | 6.75 | 26.31% | |
| ISMD | Inspire Small/Mid Cap Impact ETF | 46.88 | 9.94 | 26.91% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.